ArticleAmerican health & drug benefits2015

Estimating the Costs of Therapy in Patients with Relapsed and/or Refractory Multiple Myeloma: A Model Framework.

Anuja Roy et al.PubMed ↗Full text ↗

No numbers read from the abstract.